BlackRock Fund Advisors decreased its stake in shares of Phibro Animal Health Corp. (NASDAQ:PAHC) by 0.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,353,013 shares of the company’s stock after selling 8,506 shares during the period. BlackRock Fund Advisors owned approximately 3.44% of Phibro Animal Health Corp. worth $36,585,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Russell Frank Co boosted its position in Phibro Animal Health Corp. by 256.6% in the fourth quarter. Russell Frank Co now owns 34,144 shares of the company’s stock valued at $1,049,000 after buying an additional 24,568 shares during the last quarter. Fiera Capital Corp boosted its position in Phibro Animal Health Corp. by 29.6% in the fourth quarter. Fiera Capital Corp now owns 47,300 shares of the company’s stock valued at $1,425,000 after buying an additional 10,800 shares during the last quarter. Convergence Investment Partners LLC boosted its position in Phibro Animal Health Corp. by 3.8% in the fourth quarter. Convergence Investment Partners LLC now owns 49,828 shares of the company’s stock valued at $1,501,000 after buying an additional 1,820 shares during the last quarter. Prudential Financial Inc. boosted its position in Phibro Animal Health Corp. by 8.9% in the first quarter. Prudential Financial Inc. now owns 56,200 shares of the company’s stock valued at $1,520,000 after buying an additional 4,600 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in Phibro Animal Health Corp. by 8.2% in the first quarter. Acadian Asset Management LLC now owns 74,153 shares of the company’s stock valued at $2,004,000 after buying an additional 5,616 shares during the last quarter.
Shares of Phibro Animal Health Corp. (NASDAQ:PAHC) traded up 0.49% during mid-day trading on Tuesday, hitting $20.55. The stock had a trading volume of 66,300 shares. The stock has a market cap of $809.81 million and a price-to-earnings ratio of 10.53. Phibro Animal Health Corp. has a 12-month low of $16.80 and a 12-month high of $40.40. The firm’s 50-day moving average price is $19.61 and its 200 day moving average price is $23.99.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 28th. Stockholders of record on Wednesday, September 7th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date is Friday, September 2nd.
PAHC has been the subject of several recent analyst reports. Zacks Investment Research cut Phibro Animal Health Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, March 29th. Guggenheim decreased their price target on Phibro Animal Health Corp. from $38.00 to $34.00 and set a “buy” rating for the company in a research note on Monday, April 11th. Credit Suisse Group AG reissued a “buy” rating and issued a $42.00 price target on shares of Phibro Animal Health Corp. in a research note on Monday, April 11th. Morgan Stanley reissued a “sell” rating on shares of Phibro Animal Health Corp. in a research note on Monday, April 11th. Finally, Macquarie reissued a “hold” rating on shares of Phibro Animal Health Corp. in a research note on Tuesday, April 19th. Three analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the stock. Phibro Animal Health Corp. currently has a consensus rating of “Hold” and an average price target of $35.33.
In other news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Thursday, May 19th. The stock was bought at an average cost of $18.14 per share, for a total transaction of $90,700.00. Following the purchase, the director now owns 10,000 shares of the company’s stock, valued at $181,400. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
